Patritumab Plus Erlotinib in EGFR Wild-Type Advanced Non-Small Cell Lung Cancer: A 2-Part Phase 3 Study (HER3-Lung)
JOURNAL OF THORACIC ONCOLOGY(2015)
关键词
Advanced non-small cell lung cancer,Heregulin biomarker,Phase 3 study,Patritumab
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要